ECVAM training
This article was originally published in The Rose Sheet
Executive Summary
The European Center for the Validation of Alternative Methods will hold a training course Nov. 28-30 on validated in vitro alternatives to topical toxicity testing. The training will focus on the in vitro skin irritation test, the in vitro 3T3 NRU phototoxicity test and the HET-CAM test. The course - to be held in conjunction with the Institute of Pharmacy at the Freie Universität Berlin and the German Federal Institute for Risk Assessment - will take place in Berlin at the Institute of Pharmacy. Representatives from industry, government and academia are invited...
You may also be interested in...
Cullinan Changes Tracks, Moving Lymphoma Bispecific Into Autoimmune
The company will discontinue its trial of the CD19-directed bispecific CLN-978 in NHL and develop it in inflammatory diseases, where it could have an edge over CAR-Ts.
Interview: Theradaptive To Enter Clinical Trial For Spinal Fusion Gel
Theradaptive, which makes a device-biologic combination product to help speed bone healing, recently got authorization to start human trials from the US FDA. Medtech Insight spoke to CEO Luis Alvarez about the company’s past, present and future.
US FDA Expects Joint AdComm Briefing Document, Oncology Chief Says
The combined format is the new default for briefing advisory committee members, US FDA Oncology Center of Excellence Director Pazdur declared.